LNPEP and neoplasm: After taking in tumor antigens, Vγ9Vδ2 T cells present those antigens to CD4+ αβ T cells and also utilize insulin-regulated aminopeptidase (IRAP) [79] to cross present them on MHC I molecules to prime CD8+ αβ T cells–a hallmark of professional APCs [75,77].